Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Clinical Supply Management
  6.  » Optimizing Resupply to Reduce Risk of Late Phase Delays
white paper icon

Optimizing Resupply to Reduce Risk of Late Phase Delays

Summary: As clinical studies become more complex in later phases, the risk for delays due to unexpected issues increases. This can be avoided, however. Assessing challenges early on and developing a clinical supply strategy that incorporates processes to help anticipate and mitigate these risks is critical. Working with a Clinical Supply Manager (CSM) who can help implement best practices in plan development before a study reaches late phase can be a valuable resource for sponsors.

Click here to view the article